The Executive Director of Communication for Development and Advocacy Consult (CDA Consult), Francis Ameyibor, has announced that the non-governmental organization specializing in development communication advocacy is mobilizing stakeholders to launch a robust national advocacy campaign against cervical cancer.
He emphasized CDA Consult’s goal of uniting health professionals, human rights advocates, gender activists, religious adherents, and communication practitioners to initiate a new model of advocacy.
Despite acknowledging progress in raising awareness about cervical cancer, Mr. Ameyibor stressed the need to intensify efforts, especially with the approaching 2030 Sustainable Development Goal deadline for cervical cancer eradication. He highlighted the importance of a comprehensive national action involving both state and non-state actors.
Mr. Ameyibor, also serving as the Ghana News Agency Tema Regional Manager, mentioned that the project is set to launch by the end of the first quarter of this year.
He explained that during the launch, the national programme would outline the modalities for the Change Paradigm Advocacy campaign, which focuses on free cervical cancer vaccinations, advocacy, and scaling up prevention, detection, and treatment to eliminate cervical cancer in Ghana.
Meanwhile, Dr. Chris Kpodar, former United Nations Consultant for Africa and the Middle East and a member of the Board of Directors of CDA Consult, has called for a holistic and persistent national approach to combat and reduce cervical cancer in the country.
He noted that cervical cancer is preventable with a multifaceted stakeholder approach, including policy interventions, public education, empowerment of health professionals, and targeted actions to encourage women to undergo cervical cancer screening.
The Change Paradigm campaign by CDA Consult focuses on four pillars: free cervical cancer vaccination, scaling up prevention, encouraging screening for early detection, and providing support for treatment, aiming to eliminate cervical cancer in Ghana by 2030.